A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b-Reference-Cited by-同舟云学术

A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b

Published:1998-12 Issue:12 Volume:18 Page:1025-1030
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

PUNGOR ERNO,FILES JAMES G.,GABE JEFFREY D.,DO LINH T.,FOLEY WAYNE P.,GRAY JULIA L.,NELSON JEFFREY W.,NESTAAS EIRIK,TAYLOR JERRY L.,GROSSBERG SIDNEY E.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.1998.18.1025

Reference11 articles.

1. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

2. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

3. Interferon beta-lb in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial

4. A Novel Sensitive and Selective Bioassay for Human Type I Interferons

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19

2. Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta;International Immunopharmacology;2018-09

3. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials;Multiple Sclerosis Journal;2018-03-09

4. Persistency of Neutralizing Anti-Interferon-β Antibodies in Patients with Multiple Sclerosis Treated with Subcutaneous Interferon-β Depends on Antibody Titers, IgG Subclasses, and Affinity Maturation;Journal of Interferon & Cytokine Research;2017-07

5. Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta;Journal of Immunological Methods;2016-03